Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2015

Sep 11, 2015

30198_dirs_2015-09-11_99a2e530-0064-4d0e-b723-eb5e7026b2a2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2015-09-09

Reporting Person: VALDES JORGE A (CTO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-09-09 Common Stock J 11833.0 $91.05 Disposed 104374 Direct
2015-09-09 Common Stock J 11833.0 $91.05 Acquired 18413 Indirect
2015-09-09 Common Stock D 6253.0 $90.8985 Disposed 12160 Indirect

Footnotes

F1: Shares were transferred from direct ownership to ownership under the Valdes-Lopez-Calleja Family Trust upon vesting of previously awarded restricted stock units.

F2: Included in this number are 92,437 unvested restricted stock units, 45,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 35,500 of which were granted on March 8, 2014 and shall vest through March 8, 2017, and 11,937 of which were granted on March 11, 2013 and shall vest through March 11, 2016.

F3: Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee.

F4: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.